(203) 815-5782
balmassian@carogencorp.com
Home
About
About Us
Management
AVIDIO
AVIDIO
Oncology: CARG-2020
CARG-201 for HBV
Investors and Funding Resources
News
Contact
AVIDIO
AVIDIO Platform
RNA-based artificial virus immunotherapy platform
High payload capacity for delivering multiple transgenes
Broad spectrum of immune responses
High potential for oncology and infectious diseases
CaroGen Corporation
CaroGen Corporation
(203) 815-5782
balmassian@carogencorp.com